Barrier Methods



Condoms are the most common contraceptive method used by teenagers and are the only contraceptive method that also protect against sexually transmitted infections. However, the failure rate of condoms as contraception approaches 17 % within this population, making them less reliable as contraception but extremely important in dual use context. In this chapter we discuss basic epidemiology of condom use among teenaged women and examine the contraceptive efficacy of condoms in this population. We explore the role of barrier methods in dual-method protection, discuss unique challenges and considerations young women face when engaging in condom use, and consider provider issues when discussing condom use. We will briefly touch on other barrier methods, specifically the female condom, as a possible alternative to male condoms for teenaged women.


Contraceptive Method Unintended Pregnancy Nulliparous Woman Oral Contraceptive Pill Parous Woman 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Warner L, Steiner MJ. Male condoms. In: Hatcher RA, Trussell J, Nelson AL, et al, editor. Contraceptive technology. New York, NY: Ardent Media; 2008. p. 297–316.Google Scholar
  2. 2.
    Trends in sexual risk behaviors among high school students–United States, 1991–2001. MMWR Morb Mortal Wkly Rep. 2002;51(38):856–9.Google Scholar
  3. 3.
    Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use, 2010. MMWR. 2010;59(RR-4):1–86.Google Scholar
  4. 4.
    Reece M, Herbenick D, Schick V, Sanders SA, Dodge B, Fortenberry JD. Condom use rates in a national probability sample of males and females ages 14 to 94 in the United States. J Sex Med. 2010;7 Suppl 5:266–76.PubMedCrossRefGoogle Scholar
  5. 5.
    Martinez G, Copen CE, Abma JC. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006–2010 national survey of family growth. Vital and health statistics series 23, data from the National Survey of Family. Growth. 2011;31:1–35.Google Scholar
  6. 6.
    Williams RL, Fortenberry JD. Update on adolescent condom use. Curr Opin Obstet Gynecol. 2011;23(5):350–4.PubMedCrossRefGoogle Scholar
  7. 7.
    O’Sullivan LF, Udell W, Montrose VA, Antoniello P, Hoffman S. A cognitive analysis of college students’ explanations for engaging in unprotected sexual intercourse. Arch Sex Behav. 2010;39(5):1121–31.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Conard LA, Fortenberry JD, Blythe MJ, Orr DP. Pharmacists’ attitudes toward and practices with adolescents. Arch Pediatr Adolesc Med. 2003;157(4):361–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Hoffman S, Mantell J, Exner T, Stein Z. The future of the female condom. Perspect Sex Reprod Health. 2004;36(3):120–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Eaton DK, Kann L, Kinchen S, Shanklin S, Ross J, Hawkins J, et al. Youth risk behavior surveillance–United States, 2007. MMWR Surveill Summ. 2008;57(4):1–131.PubMedGoogle Scholar
  11. 11.
    Kulczycki A, Kim DJ, Duerr A, Jamieson DJ, Macaluso M. The acceptability of the female and male condom: a randomized crossover trial. Perspect Sex Reprod Health. 2004;36(3):114–9.PubMedCrossRefGoogle Scholar
  12. 12.
    McCabe E, Golub S, Lee AC. Making the female condom a “reality” for adolescents. J Pediatr Adolesc Gynecol. 1997;10(3):115–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Haignere CS, Gold R, Maskovsky J, Ambrosini J, Rogers CL, Gollub E. High-risk adolescents and female condoms: knowledge, attitudes, and use patterns. J Adolesc Health. 2000;26(6):392–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Stone KM, Grimes DA, Magder LS. Primary prevention of sexually transmitted diseases. A primer for clinicians. JAMA. 1986;255(13):1763–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Van de Perre P, Jacobs D, Sprecher-Goldberger S. The latex condom, an efficient barrier against sexual transmission of AIDS-related viruses. AIDS. 1987;1(1):49–52.PubMedGoogle Scholar
  16. 16.
    Macaluso M, Lawson ML, Hortin G, Duerr A, Hammond KR, Blackwell R, et al. Efficacy of the female condom as a barrier to semen during intercourse. Am J Epidemiol. 2003;157(4):289–97.PubMedCrossRefGoogle Scholar
  17. 17.
    Speroff L, Darney PD. Barrier methods of contraception. A clinical guide for contraception. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.Google Scholar
  18. 18.
    Rosenberg MJ, Waugh MS. Latex condom breakage and slippage in a controlled clinical trial. Contraception. 1997;56(1):17–21.PubMedCrossRefGoogle Scholar
  19. 19.
    Crosby R, Sanders S, Yarber WL, Graham CA. Condom-use errors and problems: a neglected aspect of studies assessing condom effectiveness. Am J Prev Med. 2003;24(4):367–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Steiner MJ, Dominik R, Rountree RW, Nanda K, Dorflinger LJ. Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial. Obstet Gynecol. 2003;101(3):539–47.PubMedCrossRefGoogle Scholar
  21. 21.
    Gallo MF, Grimes DA, Lopez LM, Schulz KF. Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev. 2006;(1):CD003550.Google Scholar
  22. 22.
    Macaluso M, Blackwell R, Jamieson DJ, Kulczycki A, Chen MP, Akers R, et al. Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol. 2007;166(1):88–96.PubMedCrossRefGoogle Scholar
  23. 23.
    Trussell J, Sturgen K, Strickler J, Dominik R. Comparative contraceptive efficacy of the female condom and other barrier methods. Fam Plann Perspect. 1994;26(2):66–72.PubMedCrossRefGoogle Scholar
  24. 24.
    Cates W, Raymond E. Vaginal barriers and spermicides. In: Hatcher RA, Ttussell J, Nelson AL, et al., editors. Contraceptive technology. New York, NY: Ardent Media; 2008.Google Scholar
  25. 25.
    Fihn SD, Boyko EJ, Chen CL, Normand EH, Yarbro P, Scholes D. Use of spermicide-coated condoms and other risk factors for urinary tract infection caused by Staphylococcus saprophyticus. Arch Intern Med. 1998;158(3):281–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Fihn SD, Boyko EJ, Normand EH, Chen CL, Grafton JR, Hunt M, et al. Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am J Epidemiol. 1996;144(5):512–20.PubMedCrossRefGoogle Scholar
  27. 27.
    Handley MA, Reingold AL, Shiboski S, Padian NS. Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides. Epidemiology. 2002;13(4):431–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Fortenberry JD, Schick V, Herbenick D, Sanders SA, Dodge B, Reece M. Sexual behaviors and condom use at last vaginal intercourse: a national sample of adolescents ages 14 to 17 years. J Sex Med. 2010;7 Suppl 5:305–14.PubMedCrossRefGoogle Scholar
  29. 29.
    Hamann CP, Kick SA. Update: immediate and delayed hypersensitivity to natural rubber latex. Cutis. 1993;52(5):307–11.PubMedGoogle Scholar
  30. 30.
    Chen FC, Buscher U, Niggemann B. Condoms are not a risk factor for sensitization to latex. Contraception. 2002;66(6):439–41.PubMedCrossRefGoogle Scholar
  31. 31.
    Henry-Reid LM, O’Connor KG, Klein JD, Cooper E, Flynn P, Futterman DC. Current pediatrician practices in identifying high-risk behaviors of adolescents. Pediatrics. 2010;125(4):e741–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Martinez G, Abma J, Copen C. Educating teenagers about sex in the United States. NCHS Data Brief. 2010;44:1–8.PubMedGoogle Scholar
  33. 33.
    Jones RK, Purcell A, Singh S, Finer LB. Adolescents’ reports of parental knowledge of adolescents’ use of sexual health services and their reactions to mandated parental notification for prescription contraception. JAMA. 2005;293(3):340–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ. 2004;82(6):454–61.PubMedCentralPubMedGoogle Scholar
  35. 35.
    Warner L, Stone KM, Macaluso M, Buehler JW, Austin HD. Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis. 2006;33(1):36–51.PubMedCrossRefGoogle Scholar
  36. 36.
    Winer RL, Hughes JP, Feng Q, O’Reilly S, Kiviat NB, Holmes KK, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006;354(25):2645–54.PubMedCrossRefGoogle Scholar
  37. 37.
    Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002;(1):CD003255.Google Scholar
  38. 38.
    Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med. 2009;169(13):1233–40.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Stanaway JD, Wald A, Martin ET, Gottlieb SL, Magaret AS. Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition. Sex Transm Dis. 2012;39(5):388–93.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Rosenberg MJ, Waugh MS, Solomon HM, Lyszkowski AD. The male polyurethane condom: a review of current knowledge. Contraception. 1996;53(3):141–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Vijayakumar G, Mabude Z, Smit J, Beksinska M, Lurie M. A review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence. Int J STD AIDS. 2006;17(10):652–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Pazol K, Kramer MR, Hogue CJ. Condoms for dual protection: patterns of use with highly effective contraceptive methods. Public Health Rep. 2010;125(2):208–17.PubMedCentralPubMedGoogle Scholar
  43. 43.
    Ott MA, Adler NE, Millstein SG, Tschann JM, Ellen JM. The trade-off between hormonal contraceptives and condoms among adolescents. Perspect Sex Reprod Health. 2002;34(1):6–14.PubMedCrossRefGoogle Scholar
  44. 44.
    Roye CF. Condom use by Hispanic and African-American adolescent girls who use hormonal contraception. J Adolesc Health. 1998;23(4):205–11.PubMedCrossRefGoogle Scholar
  45. 45.
    Santelli JS, Warren CW, Lowry R, Sogolow E, Collins J, Kann L, et al. The use of condoms with other contraceptive methods among young men and women. Fam Plann Perspect. 1997;29(6):261–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Anderson JE, Santelli J, Gilbert BC. Adolescent dual use of condoms and hormonal contraception: trends and correlates 1991–2001. Sex Transm Dis. 2003;30(9):719–22.PubMedCrossRefGoogle Scholar
  47. 47.
    Brown JL, Hennessy M, Sales JM, DiClemente RJ, Salazar LF, Vanable PA, et al. Multiple method contraception use among African American adolescents in four US cities. Infect Dis Obstet Gynecol. 2011;2011:765917.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Manning WD, Longmore MA, Giordano PC. The relationship context of contraceptive use at first intercourse. Fam Plann Perspect. 2000;32(3):104–10.PubMedCrossRefGoogle Scholar
  49. 49.
    Crosby RA, DiClemente RJ, Wingood GM, Sionean C, Cobb BK, Harrington K, et al. Correlates of using dual methods for sexually transmitted diseases and pregnancy prevention among high-risk African-American female teens. J Adolesc Health. 2001;28(5):410–4.PubMedCrossRefGoogle Scholar
  50. 50.
    Riehman KS, Sly DF, Soler H, Eberstein IW, Quadagno D, Harrison DF. Dual-method use among an ethnically diverse group of women at risk of HIV infection. Fam Plann Perspect. 1998;30(5):212–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Cook L, Nanda K, Grimes D. Diaphragm versus diaphragm with spermicides for contraception. Cochrane Database Syst Rev. 2002;(3):CD002031.Google Scholar
  52. 52.
    Gallo MF, Grimes DA, Schulz KF. Cervical cap versus diaphragm for contraception. Cochrane Database Syst Rev. 2002;(4):CD003551.Google Scholar
  53. 53.
    Kuyoh MA, Toroitich-Ruto C, Grimes DA, Schulz KF, Gallo MF. Sponge versus diaphragm for contraception: a Cochrane review. Contraception. 2003;67(1):15–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Grimes DA, Lopez L, Raymond EG, Halpern V, Nanda K, Schulz KF. Spermicide used alone for contraception. Cochrane Database Syst Rev. 2005;(4):CD005218.Google Scholar
  55. 55.
    Kiley J, Sobrero A. Use and effectiveness of barrier and spermicidal contraceptive methods. The Global Library of Women’s Medicine (ISSN: 1756–2228) 2008. doi:10.3843/GLOWM.10385.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, Section of Family Planning and Contraceptive ResearchThe University of ChicagoChicagoUSA

Personalised recommendations